Literature DB >> 277925

Changes in genome composition of the Friend virus complex in erythroleukemia cells during the course of differentiation induced by dimethyl sulfoxide.

W Ostertag, I B Pragnell.   

Abstract

The Friend spleen focus-forming virus (SFFV) complex released by Friend virus-transformed erythroid cells has been analyzed with respect to changes in the genome composition that may occur during induction of erythropoiesis with dimethyl sulfoxide. It is shown that: (a) There are three types of virus particles, one with buoyant density 1.20 g/ml, one with density 1.17 g/ml (the density of the cloned lymphatic leukemia virus helper component of the complex), and a major fraction that has a density of 1.14 g/ml. (b) Three RNA subunits-35S, 32S, and 30S-have previously been shown to be detectable in the Friend virus complex. The 1.20-g/ml particles contain only 30S RNA, whilst the 1.14- to 1.17-g/ml particles contain a mixture consisting of predominantly 30S and 32S RNA and about 5-10% 35S RNA. (c) Induction of differentiation results in an increase in the 1.14-g/ml particles and 32S RNA. The amount of 30S RNA does not change. (d) Hybridization of the different genomic viral RNAs with full-length virus cDNA shows that the 30S RNA (of induced and uninduced Friend virus) is more closely related to the 32S RNA of the induced Friend virus than to the 32S RNA of the constitutively released Friend virus. (e) The 30S RNA contains SFFV-specific sequences. (f) A hypothesis is presented in which the induction of the new 32S RNA species is related to the increase of SFFV activity and to a specific function of the SFFV during induction of erythropoiesis.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 277925      PMCID: PMC392758          DOI: 10.1073/pnas.75.7.3278

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  17 in total

Review 1.  Editorial: Spleen focus-forming virus in Friend and Rauscher leukemia virus preparations.

Authors:  R A Steeves
Journal:  J Natl Cancer Inst       Date:  1975-02       Impact factor: 13.506

2.  Rescue of endogenous 30S retroviral sequences from mouse cells by baboon type C virus.

Authors:  S A Sherwin; U R Rapp; R E Benveniste; A Sen; G J Todaro
Journal:  J Virol       Date:  1978-05       Impact factor: 5.103

3.  Friend strain of spleen focus-forming virus is a recombinant between ecotropic murine type C virus and the env gene region of xenotropic type C virus.

Authors:  D H Troxler; D Lowy; R Howk; H Young; E M Scolnick
Journal:  Proc Natl Acad Sci U S A       Date:  1977-10       Impact factor: 11.205

4.  Defective Friend spleen focus-forming virus: interfering properties and isolation free from standard leukemia-inducing helper virus.

Authors:  R J Eckner; K L Hettrick
Journal:  J Virol       Date:  1977-10       Impact factor: 5.103

5.  Size, subunit composition, and secondary structure of the Friend virus genome.

Authors:  S Dube; H J Kung; W Bender; N Davidson; W Ostertag
Journal:  J Virol       Date:  1976-10       Impact factor: 5.103

6.  Are spleen focus-forming virus sequences related to xenotropic viruses and expressed specifically in normal erythroid cells?

Authors:  I B Pragnell; A McNab; P R Harrison; W Osterag
Journal:  Nature       Date:  1978-03-30       Impact factor: 49.962

7.  The expression of viral and globin genes during differentiation of the Friend cell.

Authors:  I B Pragnell; W Ostertag; J Paul
Journal:  Exp Cell Res       Date:  1977-09       Impact factor: 3.905

8.  RNA-dependent DNA polymerase and ribonuclease H from Friend virions.

Authors:  B J Weimann; J Schmidt; D I Wolfrum
Journal:  FEBS Lett       Date:  1974-07-01       Impact factor: 4.124

9.  Synthesis of mouse haemoglobin and globin mRNA in leukaemic cell cultures.

Authors:  W Ostertag; H Melderis; G Steinheider; N Kluge; S Dube
Journal:  Nat New Biol       Date:  1972-10-25

10.  Cell-free transmission in adult Swiss mice of a disease having the character of a leukemia.

Authors:  C FRIEND
Journal:  J Exp Med       Date:  1957-04-01       Impact factor: 14.307

View more
  7 in total

1.  Variations in properties of virus released from morphologically different cell lines transformed in vitro by Friend leukemia virus.

Authors:  D Tsuei; B G Pogo; C Friend
Journal:  Proc Natl Acad Sci U S A       Date:  1980-10       Impact factor: 11.205

2.  A neutralizable epitope common to the envelope glycoproteins of ecotropic, polytropic, xenotropic, and amphotropic murine leukemia viruses.

Authors:  L H Evans; R P Morrison; F G Malik; J Portis; W J Britt
Journal:  J Virol       Date:  1990-12       Impact factor: 5.103

3.  Analysis of two monoclonal antibodies reactive with envelope proteins of murine retroviruses: one pan specific antibody and one specific for Moloney leukemia virus.

Authors:  Leonard H Evans; Stefano Boi; Frank Malik; Kathy Wehrly; Karin E Peterson; Bruce Chesebro
Journal:  J Virol Methods       Date:  2014-02-17       Impact factor: 2.014

4.  Dimethyl sulfoxide affects the amount of extrachromosomal spleen focus-forming virus DNA in murine erythroleukemia cells.

Authors:  F G Kern; D E Axelrod
Journal:  J Virol       Date:  1983-04       Impact factor: 5.103

5.  Myeloproliferative virus, a cloned murine sarcoma virus with spleen focus-forming properties in adult mice.

Authors:  W Ostertag; K Vehmeyer; B Fagg; I B Pragnell; W Paetz; M C Le Bousse; F Smadja-Joffe; B Klein; C Jasmin; H Eisen
Journal:  J Virol       Date:  1980-02       Impact factor: 5.103

6.  Spleen focus-forming Friend virus: identification of genomic RNA and its relationship to helper virus RNA.

Authors:  L H Evans; P H Duesberg; D H Troxler; E M Scolnick
Journal:  J Virol       Date:  1979-07       Impact factor: 5.103

7.  Analysis of the myeloproliferative sarcoma virus genome: limited changes in the prototype lead to altered target cell specificity.

Authors:  I B Pragnell; A Fusco; C Arbuthnott; F Smadja-Joffe; B Klein; C Jasmin; W Ostertag
Journal:  J Virol       Date:  1981-06       Impact factor: 5.103

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.